SRF Limited

BSE:503806 Rapport sur les actions

Capitalisation boursière : ₹774.7b

SRF Croissance future

Future contrôle des critères 3/6

SRF devrait augmenter ses bénéfices et son chiffre d'affaires de 16.5% et de 12.2% par an respectivement. Le BPA devrait croître de de 16.9% par an. Le rendement des capitaux propres devrait être 15.8% dans 3 ans.

Informations clés

16.5%

Taux de croissance des bénéfices

16.93%

Taux de croissance du BPA

Chemicals croissance des bénéfices19.2%
Taux de croissance des recettes12.2%
Rendement futur des capitaux propres15.80%
Couverture par les analystes

Good

Dernière mise à jour17 May 2026

Mises à jour récentes de la croissance future

Recent updates

Mise à jour du récit • Apr 30

503806: Future P/E Compression Will Likely Cap Upside Despite Margin Support

The analyst price target for SRF has been adjusted from ₹2,249.74 to ₹2,200.00 as analysts factor in updated assumptions on discount rate, revenue growth, profit margin and future P/E. What's in the News SRF has scheduled a board meeting on May 05, 2026 to consider and approve the audited financial results for the quarter and year ended March 31, 2026 (company filing).
Mise à jour du récit • Apr 08

503806: Fair View As Higher Margins Offset Lower Future P/E Multiple

Analysts have raised their fair value estimate for SRF slightly, from ₹2,239.45 to ₹2,249.74. This reflects updated assumptions for revenue growth, profit margins, a lower assumed discount rate, and a reduced future P/E multiple.
Mise à jour du récit • Mar 24

503806: Elevated P E And Margins Will Likely Restrain Future Returns

Analysts have modestly increased their fair value estimate for SRF from ₹2,218.36 to ₹2,239.45, citing updated assumptions regarding revenue growth, profit margins, the discount rate, and future P/E, which together support a slightly higher price target. What's in the News SRF's board approved the appointment of Mr. Samir Kashyap as Chief Financial Officer, effective January 27, 2026.
Mise à jour du récit • Mar 09

503806: Elevated P E And Modest Margins Will Likely Restrain Future Returns

Analysts now set their fair value estimate for SRF at ₹2,218, compared with the previous ₹2,244. This reflects updated assumptions around discount rate, revenue growth, profit margins and future P/E expectations.
Mise à jour du récit • Feb 23

503806: Elevated P E And Modest Margin Outlook Will Likely Pressure Returns

Analysts have slightly raised their price target on SRF to ₹2,244, citing updated assumptions for the discount rate, revenue growth, profit margin and future P/E. These changes keep their fair value view broadly unchanged in headline terms but reflect a modestly adjusted risk and earnings profile.
Mise à jour du récit • Feb 09

503806: Lower Margins And Rich P E Will Likely Pressure Returns

Analysts have raised their price target on SRF to ₹2,244 from ₹2,213, citing updated assumptions on the discount rate, revenue growth, profit margins and a higher future P/E multiple. What's in the News The board has approved the appointment of Mr. Samir Kashyap as Chief Financial Officer, effective January 27, 2026.
Mise à jour du récit • Jan 24

503806: New Pharma Plant And CFO Appointment Will Support Future Upside

Analysts have trimmed their price target on SRF to ₹3,155.83 from ₹3,183.00, reflecting slightly more conservative assumptions on revenue growth, profit margin and future P/E, as well as a marginally higher discount rate. What's in the News Board meeting on January 20, 2026 to review unaudited financial results for the quarter and nine months ended December 31, 2025, consider a new pharma intermediate plant project, and discuss a second interim dividend for FY 2025-26 (company filing).
Mise à jour du récit • Jan 10

503806: Future Capacity Expansion And CFO Transition Will Support Long Term Prospects

Analysts have kept their fair value estimate for SRF steady at ₹3,841, with only small tweaks to assumptions such as the discount rate, revenue growth, profit margin and future P/E that feed into the updated target. This signals broadly consistent expectations compared with prior research.
Mise à jour du récit • Dec 26

503806: Future Specialty Fluoropolymer Capacity Expansion May Support Long Term Profitability

Analysts have modestly raised their price target on SRF to a new level, in line with incremental improvements in projected revenue growth, profit margins, and a slightly lower future valuation multiple, signaling a cautiously stronger outlook for the stock. What's in the News Chief Financial Officer Rahul Jain will step down from his role at the close of business on 12 December 2025, with SRF initiating the process to identify a successor and ensure a smooth transition (Key Developments).
Mise à jour du récit • Dec 12

503806: Lower Discount Rate May Support Stronger Long Term Profitability

Analysts have raised their fair value estimate for SRF by approximately $191 to $3,841 per share, citing a modestly lower discount rate and slightly higher long term profit margin expectations that more than offset a small reduction in projected revenue growth. What's in the News Chief Financial Officer Rahul Jain will step down from his role at the close of business on 12 December 2025.
Mise à jour du récit • Nov 27

503806: CFO Transition And New Facility Approval Will Drive Upside Ahead

Analysts have adjusted their price target for SRF slightly upward from $3,182.93 to $3,183.00, citing minor changes in underlying financial assumptions such as discount rate and projected margin. What's in the News Chief Financial Officer Rahul Jain will step down at the close of business on December 12, 2025.
Mise à jour du récit • Nov 12

503806: Upcoming CFO Departure And Facility Decision Will Shape Outlook

Analysts have raised their price target for SRF from $3,138.07 to $3,182.93, citing updated forecasts that reflect slight adjustments in growth and profitability assumptions. What's in the News SRF Limited's Chief Financial Officer, Rahul Jain, announced he will step down from his position at the close of business on December 12, 2025.
Mise à jour du récit • Oct 29

New Facility And Supply Chain Moves Will Drive Balanced Opportunity Ahead

Analysts have slightly raised their price target for SRF from $3,137.83 to $3,138.07, citing improved profit margin projections as well as a modest increase in anticipated revenue growth. What's in the News SRF Limited will hold a Board Meeting on October 27, 2025, to consider and approve the un-audited financial results for the quarter and half year ended September 30, 2025.
Mise à jour du récit • Oct 15

Sustainability And Capacity Upgrades Will Transform Specialty Chemicals

Analysts have increased their price target for SRF from $3,104.79 to $3,137.83, reflecting updated expectations for the company's financial outlook. What's in the News The Chemours Company and SRF Limited have signed strategic agreements to enhance the global supply chain for fluoropolymers and fluoroelastomers (Key Developments).
Mise à jour du récit • Sep 05

Sustainability And Capacity Upgrades Will Transform Specialty Chemicals

With no meaningful change in either the discount rate or forward P/E multiple, analysts have maintained SRF's fair value estimate at ₹3105. What's in the News SRF Limited has entered into strategic agreements with The Chemours Company to strengthen Chemours' global supply chain for fluoropolymers and fluoroelastomers, leveraging SRF's manufacturing capabilities.
User avatar
Nouveau récit • Nov 28

Specialty Chemicals Innovations And Global Demand Empower Revenue Growth Journey

SRF's Specialty Chemicals growth and increased production should drive revenue and improve margins due to new product launches and efficiency gains.

Prévisions de croissance des bénéfices et des revenus

BSE:503806 - Estimations futures des analystes et données financières antérieures (INR Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
3/31/2029230,01229,39517,04339,5748
3/31/2028203,05926,82712,48835,23029
3/31/2027178,19822,3397,28130,99128
3/31/2026157,86518,3527,38325,536N/A
12/31/2025154,84717,792N/AN/AN/A
9/30/2025152,63516,17614,28929,412N/A
6/30/2025150,47614,309N/AN/AN/A
3/31/2025146,93112,50812,56024,875N/A
12/31/2024139,49511,469N/AN/AN/A
9/30/2024135,11211,2932,65817,085N/A
6/30/2024132,64312,286N/AN/AN/A
3/31/2024131,38513,357-1,23120,939N/A
12/31/2023133,46914,760N/AN/AN/A
9/30/2023137,63517,334-2,97226,742N/A
6/30/2023143,13919,136N/AN/AN/A
3/31/2023148,70321,62363529,017N/A
12/31/2022146,41622,055N/AN/AN/A
9/30/2022145,17822,002-37423,714N/A
6/30/2022136,29021,016N/AN/AN/A
3/31/2022124,33718,8892,73721,057N/A
12/31/2021114,91916,647N/AN/AN/A
9/30/2021102,92414,8345,47820,051N/A
6/30/202195,54314,167N/AN/AN/A
3/31/202184,00011,9835,57317,717N/A
12/31/202076,50210,110N/AN/AN/A
9/30/202073,54310,3223,51915,172N/A
6/30/202069,9139,174-1,40911,708N/A
3/31/202072,0949,159-84713,044N/A
12/31/201978,8179,511N/AN/AN/A
9/30/201978,4117,592N/A13,433N/A
6/30/201971,2166,331N/AN/AN/A
3/31/201970,9965,916N/A8,956N/A
12/31/201872,3295,747N/AN/AN/A
9/30/201866,6605,402N/AN/AN/A
6/30/201860,3704,917N/AN/AN/A
3/31/201855,8904,617N/A6,780N/A
12/31/201753,0264,670N/AN/AN/A
9/30/201750,3854,442N/AN/AN/A
6/30/201748,9524,642N/AN/AN/A
3/31/201748,2185,150N/A6,454N/A
12/31/201645,8334,787N/AN/AN/A
9/30/201645,4594,709N/AN/AN/A
6/30/201645,9804,537N/AN/AN/A
3/31/201645,9274,299N/A10,900N/A
12/31/201545,3533,746N/AN/AN/A
9/30/201545,5113,453N/AN/AN/A
6/30/201545,7593,235N/AN/AN/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de 503806 ( 16.5% par an) est supérieure au taux d'épargne ( 6.9% ).

Bénéfices vs marché: Les bénéfices de 503806 ( 16.5% par an) devraient croître plus rapidement que le marché Indian ( 16.4% par an).

Croissance élevée des bénéfices: Les bénéfices de 503806 devraient augmenter, mais pas de manière significative.

Chiffre d'affaires vs marché: Le chiffre d'affaires de 503806 ( 12.2% par an) devrait croître plus rapidement que le marché Indian ( 10.6% par an).

Croissance élevée des revenus: Le chiffre d'affaires de 503806 ( 12.2% par an) devrait croître plus lentement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Le retour sur capitaux propres de 503806 devrait être faible dans 3 ans ( 15.8 %).

Découvrir les entreprises en croissance

7D

1Y

7D

1Y

7D

1Y

Analyse de l'entreprise et données financières

DonnéesDernière mise à jour (heure UTC)
Analyse de l'entreprise2026/05/20 02:30
Cours de l'action en fin de journée2026/05/20 00:00
Les revenus2026/03/31
Revenus annuels2026/03/31

Sources de données

Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.

PaquetDonnéesCadre temporelExemple de source américaine *
Finances de l'entreprise10 ans
  • Compte de résultat
  • Tableau des flux de trésorerie
  • Bilan
Estimations consensuelles des analystes+3 ans
  • Prévisions financières
  • Objectifs de prix des analystes
Prix du marché30 ans
  • Cours des actions
  • Dividendes, scissions et actions
Propriété10 ans
  • Actionnaires principaux
  • Délits d'initiés
Gestion10 ans
  • L'équipe dirigeante
  • Conseil d'administration
Principaux développements10 ans
  • Annonces de l'entreprise

* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.

Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.

Modèle d'analyse et flocon de neige

Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.

Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.

Indicateurs de l'industrie et du secteur

Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.

Sources des analystes

SRF Limited est couverte par 42 analystes. 31 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.

AnalysteInstitution
null null360 ONE Capital Market Private Limited
Kumar Saumya SinghAmbit Capital
Nitin BhasinAmbit Capital